Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes.

"Declaration of personal interests : TP is the inventor of FibroTest/SteatoTest and the founder of BioPredictive, the company that markets these tests. Patents belong to the French Public Organization Assistance Publique‐Hôpitaux de Paris. TP plays a role in the study design, analysis and preparation of the manuscript. TP plays also a role in the statistical analysis but to preserve an independence in this validation study the statistical analysis was duplicate by independent academic authors CL and JM, supervised by DV and SP. OD, JMC, FD and VP are BioPredictive employees organised the anonymised assessments of the BioPredictive NITs and did not play a role in the study design, data collection, decision to publish or preparation of the manuscript and only provided financial support in the form of these authors' salaries."

"Funding information"

"Trial registration number: NCT03634098."